Clinical trial
Double-Blind, Randomized, Placebo-Controlled, Phase IIb Clinical Trial to Investigate the Efficacy of RUTI® Therapeutic Vaccination as Adjuvant of Tuberculosis Chemotherapy
NCT04919239 is registered in ClinicalTrials.gov with Archivel Farma S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Randomized, Placebo-Controlled, Phase IIb Clinical Trial to Investigate the Efficacy of RUTI® Therapeutic Vaccination as Adjuvant of Tuberculosis Chemotherapy
- Lead sponsor
- Archivel Farma S.L.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 22, 2021
- Completion date
- June 19, 2025
- Enrollment
- 140 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.